Vice President of Process Chemistry at Asymchem Group
Mark McLaws, PhD, VP, CMC & Development at Asymchem. Dr. McLaws obtained a Ph.D. from the University of Utah. Dr. McLaws has over 17 years of process chemistry experience in the pharmaceutical manufacturing industry. During his career, he has supported process development and manufacturing of clinical phase and commercial small molecule APIs in a variety of therapeutic areas. At Asymchem, Dr. McLaws leads a team of technical experts to support CMC activities with a particular focus on late-stage development, validation and commercialization.